Prefiltration enhances performance of sterile filtration for glycoconjugate vaccines

2021 ◽  
Author(s):  
Zhuoshi Du ◽  
Seyed Pouria Motevalian ◽  
Brenda Carrillo Conde ◽  
Kelvin Reilly ◽  
Andrew L. Zydney
2020 ◽  
Vol 613 ◽  
pp. 118495 ◽  
Author(s):  
Parinaz Emami ◽  
Fatemeh Fallahianbijan ◽  
Erica Dinse ◽  
Seyed Pouria Motevalian ◽  
Brenda Carrillo Conde ◽  
...  

2021 ◽  
Vol 22 (3) ◽  
pp. 1309
Author(s):  
Gianmarco Gasperini ◽  
Maria Michelina Raso ◽  
Vanessa Arato ◽  
Maria Grazia Aruta ◽  
Paola Cescutti ◽  
...  

Recently, generalized modules for membrane antigens (GMMA) technology has been proposed as an alternative approach to traditional glycoconjugate vaccines for O-antigen delivery. Saccharide length is a well-known parameter that can impact the immune response induced by glycoconjugates both in terms of magnitude and quality. However, the criticality of O-antigen length on the immune response induced by GMMA-based vaccines has not been fully elucidated. Here, Shigella and Salmonella GMMA-producing strains were further mutated in order to display homogeneous polysaccharide populations of different sizes on a GMMA surface. Resulting GMMA were compared in mice immunization studies. Athymic nude mice were also used to investigate the involvement of T-cells in the immune response elicited. In contrast with what has been reported for traditional glycoconjugate vaccines and independent of the pathogen and the sugar structural characteristics, O-antigen length did not result in being a critical parameter for GMMA immunogenicity. This work supports the identification of critical quality attributes to optimize GMMA vaccine design and improve vaccine efficacy and gives insights on the nature of the immune response induced by GMMA.


Vaccines ◽  
2021 ◽  
Vol 9 (9) ◽  
pp. 1021
Author(s):  
Ayobami Adegbite ◽  
Pumtiwitt C. McCarthy

Vaccines are important in preventing disease outbreaks and controlling the spread of disease in a population. A variety of vaccines exist, including subunit, recombinant, and conjugate vaccines. Glycoconjugate vaccines have been an important tool to fight against diseases caused by a number of bacteria. Glycoconjugate vaccines are often heterogeneous. Vaccines of the future are becoming more rationally designed to have a defined oligosaccharide chain length and position of conjugation. Homogenous vaccines could play an important role in assessing the relationship between vaccine structure and immune response. This review focuses on recent advances in the chemoenzymatic production of defined bacterial oligosaccharides for vaccine development with a focus on Neisseria meningitidis and selected WHO-prioritized antibacterial resistant-pathogens. We also provide some perspective on future advances in the chemoenzymatic synthesis of well-defined oligosaccharides.


Sign in / Sign up

Export Citation Format

Share Document